Novartis Investigative Site

Fredericton, New Brunswick E3B 1G9

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria

Studies at this site

• An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib — Running, not enrolling
• A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines — Completed